Biotech stocks are all the rage right now – and within the biotech sector, deals are all the rage. Here’s a look at recent investments, licensing deals and acquisitions made by large drugmakers. CLICK HERE.
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and GATS's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.OkayPrivacy policy